What's Happening?
A study analyzing data from 62 low- and middle-income countries (LMICs) has found that four out of five people with diagnosed diabetes use glucose-lowering medication, with nearly a quarter using insulin. The study highlights significant variations in medication use across countries and regions, influenced by factors such as availability and affordability. Insulin use was notably higher in low-income countries compared to middle-income countries.
Why It's Important?
The study underscores the challenges faced by LMICs in managing diabetes, particularly regarding access to medications. It highlights the need for improved healthcare infrastructure and policies to ensure equitable access to diabetes treatments. The findings can inform national and regional drug procurement strategies and emphasize the importance of early diagnosis and treatment initiation to prevent severe diabetes complications.
AD
